Synovial fluid alpha-defensins in Lyme arthritis—a useful marker
Folia Microbiologica · 2024
DOI: 10.1007/s12223-024-01173-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Microbiologica, 2024. Verfasst von Pavel Melicherčík und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Charles University, First Faculty of Medicine and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic. Hauptthemen laut MEDLINE: Synovial Fluid, alpha-Defensins, Lyme Disease, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
Lyme arthritis, one of the possible late manifestations of Lyme borreliosis, predominantly affects the supporting joints and in adults most often occurs in the form of monoarthritis of the knee. Early diagnosis is based on clinical findings and serology. PCR detection of Borrelia in synovial fluid has become an integral part of the laboratory testing algorithm. The clinical presentation and inflammatory markers in Lyme arthritis can resemble septic arthritis. Determining the levels of alpha-defensins (human neutrophil peptide (HNP 1-3)) in synovial fluid by liquid chromatography is a highly sensitive method revealing the presence of inflammatory process. Between 2020 and 2022, we examined eleven patients with Lyme arthritis of the knee. We measured levels of HNP 1-3 from synovial fluid by HPLC in patients, and we compared it with the corresponding C-reactive protein (CRP) levels in paired serum samples. In patients diagnosed with Lyme arthritis, HNP 1-3 levels in synovial fluid ranged from 2.5 to 261 mg/L, with a median of 46.5 mg/L. Average serum CRP was 43 mg/L. The results show that elevated HNP 1-3 can be consistent with not only septic arthritis or systemic disease, but also with Lyme arthritis, especially in patients with negative culture and 16S PCR from synovial fluid. Final diagnosis must be verified by examination for anti-Borrelia antibodies from serum and synovial fluid. The aim of this work is to introduce an HPLC method for the determination of alpha-defensins as one of the possible diagnostic markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Charles University, First Faculty of Medicine and Motol University Hospital, V Úvalu 84, 150 06, Prague 5, Czech Republic.
- Department of Medical Chemistry and Clinical Biochemistry, Charles University, Second Faculty of Medicine and Motol University Hospital, V Úvalu 84, 150 06, Prague, Czech Republic.
- Department of Medical Microbiology, Charles University, Second Faculty of Medicine and Motol University Hospital, V Úvalu 84, 150 06, Prague, Czech Republic.
- Department of Rheumatology of Children and Adults, Charles University, Second Faculty of Medicine and Motol University Hospital, V Úvalu 84, 150 06, Prague, Czech Republic.
- Department of Medical Chemistry and Clinical Biochemistry, Charles University, Second Faculty of Medicine and Motol University Hospital, V Úvalu 84, 150 06, Prague, Czech Republic. eva.klapkova@email.cz.
Förderung
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Melicherčík, P., Mazura, M., Hodík, M., Dundrová, K., Landor, I., Jahoda, D., Horváth, R., Barták, V., Kizek, R., & Klapková, E. (2024). Synovial fluid alpha-defensins in Lyme arthritis—a useful marker. Folia Microbiologica. https://doi.org/10.1007/s12223-024-01173-0
Vancouver
Melicherčík P, Mazura M, Hodík M, Dundrová K, Landor I, Jahoda D, et al. Synovial fluid alpha-defensins in Lyme arthritis—a useful marker. Folia Microbiologica. 2024. doi:10.1007/s12223-024-01173-0
BibTeX
@article{Melicherk2024,
author = {Melicherčík, Pavel and Mazura, Matěj and Hodík, Martin and Dundrová, Kamila and Landor, Ivan and Jahoda, David and Horváth, Rudolf and Barták, Vladislav and Kizek, René and Klapková, Eva},
title = {Synovial fluid alpha-defensins in Lyme arthritis—a useful marker},
journal = {Folia Microbiologica},
year = {2024},
doi = {10.1007/s12223-024-01173-0}
}
EUVIMED